PMID: 2408434Jan 1, 1985Paper

Beta-thromboglobulin and fibrinopeptide A in diabetes mellitus as markers of vascular damage

Acta diabetologica latina
M C LibrentiG Pozza

Abstract

Beta-thromboglobulin (BTG) and fibrinopeptide A (FpA) were studied in 68 non-insulin dependent diabetic patients (NIDD) aged 32-81 with a mean duration of diabetes of 9 +/- 0.8 SEM years and 44 healthy controls, comparable for age and sex. Diabetic patients were subdivided into subsets according to the presence of microvascular disease, macrovascular disease or the absence of these lesions. Patients with microangiopathy (micro- and/or macrovascular disease) had higher HbA1 (a-c) (p less than 0.01), higher blood pressure (p less than 0.05) than both healthy controls and uncomplicated diabetics. Plasma BTG was higher in diabetic patients than in healthy controls (p less than 0.02), and was higher in complicated than in non-complicated diabetic subjects. Fpa was higher in complicated than in non-complicated diabetes (p less than 0.05). No differences were observed between the two subsets of complicated patients. In conclusion, we have shown that increased plasma- and platelet-BTG levels are present in non-insulin dependent diabetic subjects, with normal renal function and that plasma BTG is higher in patients with than in those without vascular disease. Fibrinopeptide A, a sensitive marker of in vivo fibrin formation, was signific...Continue Reading

References

Aug 9, 1975·Lancet·C A LudlamJ D Cash
Jun 1, 1976·British Journal of Haematology·C A Ludlam, J D Cash
Dec 1, 1977·Diabetes·I W CampbellJ D Cash
Feb 4, 1978·Lancet·A W BurrowsT D Hockaday
Nov 1, 1979·Scandinavian Journal of Haematology·J H MatthewsJ K Wood
Dec 1, 1977·Vrachebnoe delo·P N Bodnar, S I Bortnichuk
Nov 1, 1976·The Journal of Clinical Investigation·H L NosselV P Butler
Jul 1, 1974·The Journal of Clinical Investigation·H L NosselG D Qureshi
Aug 1, 1981·European Journal of Clinical Investigation·D J BetteridgeD J Galton
Feb 1, 1981·The American Journal of Medicine·R L Jones, C M Peterson
Nov 1, 1962·Clinica Chimica Acta; International Journal of Clinical Chemistry·A L BABSONG E PHILLIPS

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.